Bernard A. Fox: A new generation of immunotherapy clinical trials

Bernard A. Fox, Co-Founder and CEO of UbiVac shared on LinkedIn:

“Great to be in Marseille with colleagues from Switzerland, Germany, Canada, and Singapore for the review of the Immunopole Pioneer Project efforts to cure patients of lung cancer. This 6 yr program has accumulated a wealth of blood and tissue biomarkers that are an incredible resource and will aid in the development of a new generation of immunotherapy clinical trials! BRAVO Fabrice Barlesi & the entire team who contributed to this effort. The meetings were held in what was Marseille’s 1st medical school Aix-Marseille Université (AMU) and overlook the Marina that will be the Paris 2024 International Olympic Committee – IOC sailing venue.”

Source: Bernard A. Fox/LinkedIn
.